Literature DB >> 16563395

Prognostic factors in node-positive patients with stage IB-IIB cervical cancer treated by radical hysterectomy and pelvic lymphadenectomy.

J Kodama1, N Seki, Y Ojima, K Nakamura, A Hongo, Y Hiramatsu.   

Abstract

OBJECTIVE: The purpose of the present study was to identify prognostic factors in surgically treated patients with stage IB-IIB cervical cancers, who also presented with positive pelvic nodes.
METHOD: The patient population consisted of 68 individuals presenting with stage IB-IIB cervical cancers and with histologically proven pelvic lymph nodes. RESULT: We found no association between the type of adjuvant therapy and patient outcome. Multivariate analysis revealed that non-squamous histology was an independent prognostic factor for disease-free and overall survival rates. In squamous cell carcinomas, the bilateral nature of the positive nodes was found to be a significant factor for disease-free survival rates. In non-squamous cell carcinomas, positive nodes of more than 2 cm in size were found to be a significant factor for disease-free survival rates.
CONCLUSION: Non-squamous histology was an independent prognostic factor and chemoradiotherapy did not improve the survival outcomes of the patients in this study population.

Entities:  

Mesh:

Year:  2006        PMID: 16563395     DOI: 10.1016/j.ijgo.2006.02.012

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  9 in total

1.  Survival and prognosticators of node-positive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.

Authors:  Masayoshi Hosaka; Hidemichi Watari; Takashi Mitamura; Yousuke Konno; Tetsuji Odagiri; Tatsuya Kato; Mahito Takeda; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2010-09-15       Impact factor: 3.402

2.  Can pelvic lymphadenectomy be omitted in patients with stage IA2, IB1, and IIA1 squamous cell cervical cancer?

Authors:  Yaxian Wang; Tingting Yao; Jin Yu; Jing Li; Qionghua Chen; Zhongqiu Lin
Journal:  Springerplus       Date:  2016-08-05

3.  Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer.

Authors:  Juan Zhou; San-Gang Wu; Jia-Yuan Sun; Xu-Lin Liao; Feng-Yan Li; Huan-Xin Lin; Li-Chao Yang; Zhen-Yu He
Journal:  Oncotarget       Date:  2017-04-18

4.  Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  BMC Cancer       Date:  2017-12-12       Impact factor: 4.430

5.  Prediction of 10-year Overall Survival in Patients with Operable Cervical Cancer using a Probabilistic Neural Network.

Authors:  Bogdan Obrzut; Maciej Kusy; Andrzej Semczuk; Marzanna Obrzut; Jacek Kluska
Journal:  J Cancer       Date:  2019-07-10       Impact factor: 4.207

Review 6.  Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.

Authors:  Fengying Qin; Huiting Pang; Tao Yu; Yahong Luo; Yue Dong
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

7.  Angiogenesis and lymphangiogenesis as prognostic factors after therapy in patients with cervical cancer.

Authors:  Marta Biedka; Roman Makarewicz; Ewa Kopczyńska; Andrzej Marszałek; Alina Goralewska; Hanna Kardymowicz
Journal:  Contemp Oncol (Pozn)       Date:  2012-02-29

8.  The influence of number of high risk factors on clinical outcomes in patients with early-stage cervical cancer after radical hysterectomy and adjuvant chemoradiation.

Authors:  Soyi Lim; Seok-Ho Lee; Kwang Beom Lee; Chan-Yong Park
Journal:  Obstet Gynecol Sci       Date:  2016-05-13

9.  Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy.

Authors:  Jinju Oh; Ki Ho Seol; Youn Seok Choi; Jeong Won Lee; Jin Young Bae
Journal:  Yeungnam Univ J Med       Date:  2019-02-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.